Series A, Series B
$1.0M – $15.0M
73+ companies
11 partners
Investment Thesis
European healthcare VC investing in innovative therapeutics and medtech with strong clinical validation and IP.
Meet the Team
Julien Ternisien
Partner
Thierry Laugel
Managing Partner
Alain Horvais
Partner
Peter Neubeck
Partner
Industry Focus
Invests In
Portfolio Companies (73)
Other
MD Start (portfolio companies)
SparingVision (N/A)
Adcytherix
Cell therapy company developing immunotherapies
Altamira Therapeutics
Therapeutic development
Alveus Therapeutics
Therapeutic development company
Amolyt Pharma
Pharmaceutical development company
AM Pharma
Pharmaceutical company
Argobio Studio
Biotech research and development
Arkhn
Asceneuron
Neuroscience therapeutics
- •Raising at Series A, Series B? You're squarely in their sweet spot.
- •Lead with your fit in Other, EdTech, Healthcare — the sectors they actively back.
- •Size your ask to their typical $1.0M – $15.0M check.
- •warm intro preferred
- •Address your outreach to a specific partner, such as Daniel Parera, Partner.
- •A warm introduction beats a cold email. Get matched and request an intro.
Featured In
Browse More Investors
Fundraising resources
Frequently Asked Questions
See if Kurma Partners is a match for your startup
Upload your pitch deck to see how well you match with Kurma Partners and 10,000+ other investors.
Is this your profile? Request a correction or removal